echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Diabetes Care: What is the relationship between metformin, vitamin B12 and all-cause mortality in diabetic patients?

    Diabetes Care: What is the relationship between metformin, vitamin B12 and all-cause mortality in diabetic patients?

    • Last Update: 2022-04-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The prevalence of diabetes worldwide has quadrupled over the past few decades, with type 2 diabetes accounting for 90%


    The prevalence of diabetes worldwide has quadrupled over the past few decades, with type 2 diabetes accounting for 90%


    Clinical studies have found that the prevalence of vitamin B12 deficiency is significantly increased in diabetic patients, especially those taking metformin


    The study included 3277 adults with type 2 diabetes from the National Health and Nutrition Examination Survey (NHANES) and were followed through December 31, 2015


    The study included 3277 adults with type 2 diabetes from the National Health and Nutrition Examination Survey (NHANES) and were followed through December 31, 2015


    Results showed that 865 all-cause deaths occurred during a median follow-up of 7.


    Association of all-cause mortality with reduced sensitivity to cobalamin (vitamin B12) in diabetic patients

    The relationship between all-cause mortality and decreased sensitivity to cobalamin (vitamin B12) in patients with diabetes B12) Relationship with reduced sensitivity

    Cobalamin sensitivity was assessed by the combination of binary B12low/high and MMAlow/high


    Cobalamin sensitivity was assessed by the combination of binary B12low/high and MMAlow/high


    In simple terms, serum and dietary vitamin B12 were not associated with reduced mortality


    References: Shanjie Wang, Ye Wang, Xin Wan, Junchen Guo, Yiying Zhang, Maoyi Tian, ​​Shaohong Fang, Bo Yu; Cobalamin Intake and Related Biomarkers: Examining Associations With Mortality Risk Among Adults With Type 2 Diabetes in NHANES.
    Diabetes Care1 February 2022; 45 (2): 276–284.
    https://doi.
    org/10.
    2337/dc21-1674 References: Shanjie Wang, Ye Wang, Xin Wan, Junchen Guo, Yiying Zhang, Maoyi Tian, ​​Shaohong Fang, Bo Yu; Cobalamin Intake and Related Biomarkers: Examining Associations With Mortality Risk Among Adults With Type 2 Diabetes in NHANES.
      Diabetes Care  1 February 2022; 45 (2): 276–284.
      https://doi.
    org/10.
    2337/dc21-1674Shanjie Wang, Ye Wang, Xin Wan, Junchen Guo, Yiying Zhang, Maoyi Tian, ​​Shaohong Fang, Bo Yu; Cobalamin Intake and Related Biomarkers: Examining Associations With Mortality Risk Among Adults With Type 2 Diabetes in NHANES.
      Diabetes Care Diabetes Care  1 February 2022; 45 (2): 276–284.
      https://doi.
    org/10.
    2337/dc21-1674

    Leave a comment here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.